Marwan G Fakih MD

Oncology•Duarte, CA

Gastrointestinal Cancer, Hematologic Oncology

Professor Section Head, Gastrointestinal Oncology Medical Director, Briskin Center for Clinical Research

Join to View Full Profile

Medical Oncology and Therapeutics Research1500 East Duarte RoadDuarte, CA 91010
Phone+1 626-256-4673

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1998 - 2001
Wayne State University School of MedicineResidency, Internal Medicine, 1992 - 1995
American University of Beirut Faculty of MedicineClass of 1992

Certifications & Licensure

CA State Medical License 2012 - 2025
MI State Medical License 1994 - 2015
NY State Medical License 2002 - 2011
PA State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Start of enrollment: 2023 Jul 12
RECRUITING
PHASE1
Roles: Contact
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Start of enrollment: 2021 Apr 11
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact
Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients with Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy Start of enrollment: 2023 May 11
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact, Principal Investigator
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation Start of enrollment: 2024 Feb 05
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
GCC19CART for Patients With Metastatic Colorectal Cancer Start of enrollment: 2022 Aug 01
Recruiting
Phase 1
Roles: Contact
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults with Select Solid Tumors Start of enrollment: 2023 Feb 15
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer Start of enrollment: 2023 May 03
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in ChemorefractoryG12C Colorectal Cancer.
Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, David Paez Lopez-Bravo
Journal of Clinical Oncology. 2025-04-11
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients WithWild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.
Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan Jr, Crystal S Denlinger, Marwan Fakih
Journal of Clinical Oncology. 2025-04-10
1 citations
An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study.
Caiming Xu, Alessandro Mannucci, Francis Esposito, Helena Oliveres, Vicente Alonso-Orduña
Clinical Cancer Research. 2025-03-17

Press Mentions

New Drug Combination Brings Hope for Treatment-Resistant Colon CancerApril 24th, 2025
For Colon Cancer That No Longer Responds to Treatment, a New Drug Combination Offers HopeApril 24th, 2025
The Mystery of What’s Causing Young People’s Cancer Leads to the GutJanuary 3rd, 2025
Join now to see all

Marwan G Fakih MD

Dr. Fakih is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.